- Home
- BFS vs IMTX Comparison
BFS vs IMTX Comparison
Compare BFS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFS
- IMTX
- Stock Information
- Founded
- BFS 1993
- IMTX N/A
- Country
- BFS United States
- IMTX Germany
- Employees
- BFS N/A
- IMTX N/A
- Industry
- BFS Real Estate Investment Trusts
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFS Real Estate
- IMTX Health Care
- Exchange
- BFS Nasdaq
- IMTX Nasdaq
- Market Cap
- BFS 770.5M
- IMTX 865.5M
- IPO Year
- BFS 1993
- IMTX N/A
- Fundamental
- Price
- BFS $31.52
- IMTX $9.20
- Analyst Decision
- BFS
- IMTX Strong Buy
- Analyst Count
- BFS 0
- IMTX 5
- Target Price
- BFS N/A
- IMTX $15.00
- AVG Volume (30 Days)
- BFS 66.6K
- IMTX 800.4K
- Earning Date
- BFS 11-06-2025
- IMTX 11-17-2025
- Dividend Yield
- BFS 7.54%
- IMTX N/A
- EPS Growth
- BFS N/A
- IMTX N/A
- EPS
- BFS 1.32
- IMTX N/A
- Revenue
- BFS $277,902,000.00
- IMTX $152,823,253.00
- Revenue This Year
- BFS $6.92
- IMTX N/A
- Revenue Next Year
- BFS $4.90
- IMTX N/A
- P/E Ratio
- BFS $23.72
- IMTX N/A
- Revenue Growth
- BFS 5.23
- IMTX 83.61
- 52 Week Low
- BFS $31.15
- IMTX $3.30
- 52 Week High
- BFS $42.39
- IMTX $11.40
- Technical
- Relative Strength Index (RSI)
- BFS 42.19
- IMTX 73.85
- Support Level
- BFS $31.28
- IMTX $6.90
- Resistance Level
- BFS $32.06
- IMTX $9.54
- Average True Range (ATR)
- BFS 0.54
- IMTX 0.47
- MACD
- BFS -0.01
- IMTX 0.23
- Stochastic Oscillator
- BFS 32.41
- IMTX 88.02
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.